Total Funding
33
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 33 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
104866
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
Risto Lammintausta: Co-Founder & CEO
About the Company
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases. The company's drugs are competent in tissue-specific hormone mechanisms for the treatment of broader gynecological conditions and Fispemifene, a novel SERM, enabling medical companies to improve the treatment of male
urological conditions and giving new opportunities to unmet needs in women's and men's health.
